Cecha
Anxiety
Intense feelings of nervousness, tension, or panic often arise in response to interpersonal stresses. There is worry about the negative effects of past unpleasant experiences and future negative possibilities. Individuals may feel fearful, apprehensive, or threatened by uncertainty, and they may also have fears of falling apart or losing control.
Podsumowanie
- Znana także jako
- Anxiety disease, Excessive, persistent worry and fear, Anxiousness
- Układ organizmu
- Abnormality of the nervous system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Anxiety, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test501 genów powiązanych z Anxiety
Zmiany w tych genach powodują rzadkie choroby, w których występuje Anxiety. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ABCC9ATP binding cassette subfamily C member 9 | Zawsze | W 1 chorobie |
| ADCY5adenylate cyclase 5 | Zawsze | W 2 chorobach |
| ALG14ALG14 UDP-N-acetylglucosaminyltransferase subunit | Zawsze | W 1 chorobie |
| ARHGEF15Rho guanine nucleotide exchange factor 15 | Zawsze | W 1 chorobie |
| ASH1LASH1 like histone lysine methyltransferase | Zawsze | W 1 chorobie |
| CACHD1cache domain containing 1 | Zawsze | W 1 chorobie |
| CST3cystatin C | Zawsze | W 1 chorobie |
| EIF2AK1eukaryotic translation initiation factor 2 alpha kinase 1 | Zawsze | W 1 chorobie |
| EMC10ER membrane protein complex subunit 10 | Zawsze | W 1 chorobie |
| FDXRferredoxin reductase | Zawsze | W 1 chorobie |
| FOXP1forkhead box P1 | Zawsze | W 2 chorobach |
| FRYLFRY like transcription coactivator | Zawsze | W 1 chorobie |
| HTRA1HtrA serine peptidase 1 | Zawsze | W 1 chorobie |
| KDM6Blysine demethylase 6B | Zawsze | W 1 chorobie |
| LRRC7leucine rich repeat containing 7 | Zawsze | W 1 chorobie |
| LSM7LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated | Zawsze | W 1 chorobie |
| MARK2microtubule affinity regulating kinase 2 | Zawsze | W 1 chorobie |
| MAU2MAU2 sister chromatid cohesion factor | Zawsze | W 2 chorobach |
| MED16mediator complex subunit 16 | Zawsze | W 1 chorobie |
| NAV3neuron navigator 3 | Zawsze | W 1 chorobie |
| NFIXnuclear factor I X | Zawsze | W 2 chorobach |
| NSD2nuclear receptor binding SET domain protein 2 | Zawsze | W 1 chorobie |
| PARK7Parkinsonism associated deglycase | Zawsze | W 2 chorobach |
| PHIPPHIP subunit of CUL4-Ring ligase complex | Zawsze | W 1 chorobie |
| POLG2DNA polymerase gamma 2, accessory subunit | Zawsze | W 2 chorobach |
| RAB32RAB32, member RAS oncogene family | Zawsze | W 1 chorobie |
| RAB3ARAB3A, member RAS oncogene family | Zawsze | W 1 chorobie |
| RNU4-2RNA, U4 small nuclear 2 | Zawsze | W 1 chorobie |
| SHQ1SHQ1, H/ACA ribonucleoprotein assembly factor | Zawsze | W 1 chorobie |
| SLC13A1solute carrier family 13 member 1 | Zawsze | W 1 chorobie |
| UBR5ubiquitin protein ligase E3 component n-recognin 5 | Zawsze | W 1 chorobie |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Zawsze | W 1 chorobie |
| UNC13Aunc-13 homolog A | Zawsze | W 2 chorobach |
| UQCRC1ubiquinol-cytochrome c reductase core protein 1 | Zawsze | W 1 chorobie |
| YWHAZtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | Zawsze | W 1 chorobie |
| AGO1argonaute RISC component 1 | Bardzo często (80–99%) | W 1 chorobie |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Bardzo często (80–99%) | W 1 chorobie |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Bardzo często (80–99%) | W 1 chorobie |
| CASRcalcium sensing receptor | Bardzo często (80–99%) | W 1 chorobie |
| CLIP2CAP-Gly domain containing linker protein 2 | Bardzo często (80–99%) | W 1 chorobie |
Pokaż jeszcze 461 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| CLTRNcollectrin, amino acid transport regulator | Bardzo często (80–99%) | W 1 chorobie |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Bardzo często (80–99%) | W 1 chorobie |
| EIF4Heukaryotic translation initiation factor 4H | Bardzo często (80–99%) | W 1 chorobie |
| ELNelastin | Bardzo często (80–99%) | W 2 chorobach |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Bardzo często (80–99%) | W 1 chorobie |
| GNA11G protein subunit alpha 11 | Bardzo często (80–99%) | W 1 chorobie |
| GTF2Igeneral transcription factor IIi | Bardzo często (80–99%) | W 1 chorobie |
| GTF2IRD1GTF2I repeat domain containing 1 | Bardzo często (80–99%) | W 1 chorobie |
| GTF2IRD2GTF2I repeat domain containing 2 | Bardzo często (80–99%) | W 1 chorobie |
| KPTNkaptin, actin binding protein | Bardzo często (80–99%) | W 2 chorobach |
| LIMK1LIM domain kinase 1 | Bardzo często (80–99%) | W 1 chorobie |
| METTL27methyltransferase like 27 | Bardzo często (80–99%) | W 1 chorobie |
| MLXIPLMLX interacting protein like | Bardzo często (80–99%) | W 1 chorobie |
| NCF1neutrophil cytosolic factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Bardzo często (80–99%) | W 1 chorobie |
| PHF21APHD finger protein 21A | Bardzo często (80–99%) | W 1 chorobie |
| PRNPprion protein (Kanno blood group) | Bardzo często (80–99%) | W 5 chorobach |
| RAI1retinoic acid induced 1 | Bardzo często (80–99%) | W 2 chorobach |
| RFC2replication factor C subunit 2 | Bardzo często (80–99%) | W 1 chorobie |
| SLC6A19solute carrier family 6 member 19 | Bardzo często (80–99%) | W 1 chorobie |
| SLITRK2SLIT and NTRK like family member 2 | Bardzo często (80–99%) | W 1 chorobie |
| STX1Asyntaxin 1A | Bardzo często (80–99%) | W 2 chorobach |
| TBL2transducin beta like 2 | Bardzo często (80–99%) | W 1 chorobie |
| TMEM270transmembrane protein 270 | Bardzo często (80–99%) | W 1 chorobie |
| VPS37DVPS37D subunit of ESCRT-I | Bardzo często (80–99%) | W 1 chorobie |
| WFS1wolframin ER transmembrane glycoprotein | Bardzo często (80–99%) | W 2 chorobach |
| ADNPactivity dependent neuroprotector homeobox | Często (30–79%) | W 2 chorobach |
| AHDC1AT-hook DNA binding motif containing 1 | Często (30–79%) | W 1 chorobie |
| AIPAHR interacting HSP90 co-chaperone | Często (30–79%) | W 1 chorobie |
| ANGangiogenin | Często (30–79%) | W 1 chorobie |
| ANXA11annexin A11 | Często (30–79%) | W 1 chorobie |
| ARandrogen receptor | Często (30–79%) | W 2 chorobach |
| ARVCFARVCF delta catenin family member | Często (30–79%) | W 1 chorobie |
| ATMATM serine/threonine kinase | Często (30–79%) | W 1 chorobie |
| ATXN2ataxin 2 | Często (30–79%) | W 1 chorobie |
| BMPR1Abone morphogenetic protein receptor type 1A | Często (30–79%) | W 1 chorobie |
| BPTFbromodomain PHD finger transcription factor | Często (30–79%) | W 1 chorobie |
| BRCA2BRCA2 DNA repair associated | Często (30–79%) | W 1 chorobie |
| BRD4bromodomain containing 4 | Często (30–79%) | W 1 chorobie |
| C1Rcomplement C1r | Często (30–79%) | W 1 chorobie |
| C1Scomplement C1s | Często (30–79%) | W 1 chorobie |
| CCNFcyclin F | Często (30–79%) | W 1 chorobie |
| CDKN2Acyclin dependent kinase inhibitor 2A | Często (30–79%) | W 1 chorobie |
| CDONcell adhesion associated, oncogene regulated | Często (30–79%) | W 4 chorobach |
| CFAP410cilia and flagella associated protein 410 | Często (30–79%) | W 1 chorobie |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Często (30–79%) | W 1 chorobie |
| CHD7chromodomain helicase DNA binding protein 7 | Często (30–79%) | W 1 chorobie |
| CHD8chromodomain helicase DNA binding protein 8 | Często (30–79%) | W 1 chorobie |
| CHEK2checkpoint kinase 2 | Często (30–79%) | W 1 chorobie |
| CHMP2Bcharged multivesicular body protein 2B | Często (30–79%) | W 2 chorobach |
| CLCN3Cl-/H+ antiporter 3 | Często (30–79%) | W 1 chorobie |
| CMPK2cytidine/uridine monophosphate kinase 2 | Często (30–79%) | W 1 chorobie |
| COL7A1collagen type VII alpha 1 chain | Często (30–79%) | W 2 chorobach |
| COMTcatechol-O-methyltransferase | Często (30–79%) | W 1 chorobie |
| COQ2coenzyme Q2, polyprenyltransferase | Często (30–79%) | W 2 chorobach |
| CRIPTOcripto, EGF-CFC family member | Często (30–79%) | W 4 chorobach |
| CTNNB1catenin beta 1 | Często (30–79%) | W 1 chorobie |
| CTSHcathepsin H | Często (30–79%) | W 1 chorobie |
| DAOD-amino acid oxidase | Często (30–79%) | W 1 chorobie |
| DCTN1dynactin subunit 1 | Często (30–79%) | W 2 chorobach |
| DENND5ADENN domain containing 5A | Często (30–79%) | W 1 chorobie |
| DISP1dispatched RND transporter family member 1 | Często (30–79%) | W 4 chorobach |
| DLL1delta like canonical Notch ligand 1 | Często (30–79%) | W 4 chorobach |
| DRD2dopamine receptor D2 | Często (30–79%) | W 1 chorobie |
| DUSP6dual specificity phosphatase 6 | Często (30–79%) | W 1 chorobie |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Często (30–79%) | W 2 chorobach |
| EMX2empty spiracles homeobox 2 | Często (30–79%) | W 1 chorobie |
| EPCAMepithelial cell adhesion molecule | Często (30–79%) | W 1 chorobie |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Często (30–79%) | W 1 chorobie |
| FAM177A1family with sequence similarity 177 member A1 | Często (30–79%) | W 1 chorobie |
| FEM1Bfem-1 homolog B | Często (30–79%) | W 1 chorobie |
| FGF17fibroblast growth factor 17 | Często (30–79%) | W 1 chorobie |
| FGF8fibroblast growth factor 8 | Często (30–79%) | W 5 chorobach |
| FGFR1fibroblast growth factor receptor 1 | Często (30–79%) | W 3 chorobach |
| FIG4FIG4 phosphoinositide 5-phosphatase | Często (30–79%) | W 1 chorobie |
| FLT4fms related receptor tyrosine kinase 4 | Często (30–79%) | W 1 chorobie |
| FMR1fragile X messenger ribonucleoprotein 1 | Często (30–79%) | W 3 chorobach |
| FOXH1forkhead box H1 | Często (30–79%) | W 4 chorobach |
| FUSFUS RNA binding protein | Często (30–79%) | W 1 chorobie |
| GABRA1gamma-aminobutyric acid type A receptor subunit alpha1 | Często (30–79%) | W 2 chorobach |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Często (30–79%) | W 4 chorobach |
| GAS1growth arrest specific 1 | Często (30–79%) | W 4 chorobach |
| GCH1GTP cyclohydrolase 1 | Często (30–79%) | W 1 chorobie |
| GLE1GLE1 RNA export mediator | Często (30–79%) | W 1 chorobie |
| GLI2GLI family zinc finger 2 | Często (30–79%) | W 4 chorobach |
| GLT8D1glycosyltransferase 8 domain containing 1 | Często (30–79%) | W 1 chorobie |
| GM2Aganglioside GM2 activator | Często (30–79%) | W 1 chorobie |
| GNRH1gonadotropin releasing hormone 1 | Często (30–79%) | W 1 chorobie |
| GNRHRgonadotropin releasing hormone receptor | Często (30–79%) | W 1 chorobie |
| GP1BBglycoprotein Ib platelet subunit beta | Często (30–79%) | W 1 chorobie |
| GPR101G protein-coupled receptor 101 | Często (30–79%) | W 1 chorobie |
| GRNgranulin precursor | Często (30–79%) | W 1 chorobie |
| HCRThypocretin neuropeptide precursor | Często (30–79%) | W 1 chorobie |
| HDAC8histone deacetylase 8 | Często (30–79%) | W 1 chorobie |
| HIRAhistone cell cycle regulator | Często (30–79%) | W 1 chorobie |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Często (30–79%) | W 3 chorobach |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Często (30–79%) | W 1 chorobie |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Często (30–79%) | W 1 chorobie |
| HNRNPH2heterogeneous nuclear ribonucleoprotein H2 | Często (30–79%) | W 1 chorobie |
| HS6ST1heparan sulfate 6-O-sulfotransferase 1 | Często (30–79%) | W 1 chorobie |
| HTThuntingtin | Często (30–79%) | W 1 chorobie |
| IMPDH2inosine monophosphate dehydrogenase 2 | Często (30–79%) | W 1 chorobie |
| JAM2junctional adhesion molecule 2 | Często (30–79%) | W 1 chorobie |
| JMJD1Cjumonji domain containing 1C | Często (30–79%) | W 1 chorobie |
| KCNN2potassium calcium-activated channel subfamily N member 2 | Często (30–79%) | W 1 chorobie |
| KCTD17potassium channel tetramerization domain containing 17 | Często (30–79%) | W 2 chorobach |
| KISS1KiSS-1 metastasis suppressor | Często (30–79%) | W 1 chorobie |
| KISS1RKISS1 receptor | Często (30–79%) | W 1 chorobie |
| KMT2Alysine methyltransferase 2A | Często (30–79%) | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Często (30–79%) | W 1 chorobie |
| LARP7La ribonucleoprotein 7, transcriptional regulator | Często (30–79%) | W 2 chorobach |
| LRP12LDL receptor related protein 12 | Często (30–79%) | W 1 chorobie |
| MAPTmicrotubule associated protein tau | Często (30–79%) | W 2 chorobach |
| MATR3matrin 3 | Często (30–79%) | W 1 chorobie |
| MBD5methyl-CpG binding domain protein 5 | Często (30–79%) | W 1 chorobie |
| MECP2methyl-CpG binding protein 2 | Często (30–79%) | W 1 chorobie |
| MLH1mutL homolog 1 | Często (30–79%) | W 1 chorobie |
| MMP1matrix metallopeptidase 1 | Często (30–79%) | W 1 chorobie |
| MOGmyelin oligodendrocyte glycoprotein | Często (30–79%) | W 1 chorobie |
| MSH2mutS homolog 2 | Często (30–79%) | W 1 chorobie |
| MSH6mutS homolog 6 | Często (30–79%) | W 1 chorobie |
| MSL2MSL complex subunit 2 | Często (30–79%) | W 1 chorobie |
| MSTO1misato mitochondrial distribution and morphology regulator 1 | Często (30–79%) | W 2 chorobach |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Często (30–79%) | W 1 chorobie |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Często (30–79%) | W 1 chorobie |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Często (30–79%) | W 1 chorobie |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Często (30–79%) | W 1 chorobie |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Często (30–79%) | W 1 chorobie |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Często (30–79%) | W 1 chorobie |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Często (30–79%) | W 1 chorobie |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Często (30–79%) | W 1 chorobie |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Często (30–79%) | W 1 chorobie |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Często (30–79%) | W 1 chorobie |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Często (30–79%) | W 1 chorobie |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Często (30–79%) | W 1 chorobie |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Często (30–79%) | W 2 chorobach |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Często (30–79%) | W 1 chorobie |
| MUTYHmutY DNA glycosylase | Często (30–79%) | W 1 chorobie |
| MYORGmyogenesis regulating glycosidase | Często (30–79%) | W 1 chorobie |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Często (30–79%) | W 2 chorobach |
| NDC1NDC1 transmembrane nucleoporin | Często (30–79%) | W 1 chorobie |
| NDPnorrin cystine knot growth factor NDP | Często (30–79%) | W 1 chorobie |
| NEFHneurofilament heavy chain | Często (30–79%) | W 1 chorobie |
| NEK1NIMA related kinase 1 | Często (30–79%) | W 1 chorobie |
| NHLH2nescient helix-loop-helix 2 | Często (30–79%) | W 1 chorobie |
| NIPBLNIPBL cohesin loading factor | Często (30–79%) | W 2 chorobach |
| NODALnodal growth differentiation factor | Często (30–79%) | W 4 chorobach |
| NONOnon-POU domain containing octamer binding | Często (30–79%) | W 1 chorobie |
| NPATnuclear protein, coactivator of histone transcription | Często (30–79%) | W 1 chorobie |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Często (30–79%) | W 1 chorobie |
| NSMFNMDA receptor synaptonuclear signaling and neuronal migration factor | Często (30–79%) | W 1 chorobie |
| OPTNoptineurin | Często (30–79%) | W 1 chorobie |
| P2RY11purinergic receptor P2Y11 | Często (30–79%) | W 1 chorobie |
| PCDH19protocadherin 19 | Często (30–79%) | W 2 chorobach |
| PDGFBplatelet derived growth factor subunit B | Często (30–79%) | W 2 chorobach |
| PDGFRBplatelet derived growth factor receptor beta | Często (30–79%) | W 2 chorobach |
| PFN1profilin 1 | Często (30–79%) | W 1 chorobie |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Często (30–79%) | W 1 chorobie |
| PLCH1phospholipase C eta 1 | Często (30–79%) | W 1 chorobie |
| PMS1PMS1 homolog 1, mismatch repair system component | Często (30–79%) | W 1 chorobie |
| PMS2PMS1 homolog 2, mismatch repair system component | Często (30–79%) | W 1 chorobie |
| POGZpogo transposable element derived with ZNF domain | Często (30–79%) | W 1 chorobie |
| POLD1DNA polymerase delta 1, catalytic subunit | Często (30–79%) | W 1 chorobie |
| POLEDNA polymerase epsilon, catalytic subunit | Często (30–79%) | W 1 chorobie |
| POLGDNA polymerase gamma, catalytic subunit | Często (30–79%) | W 2 chorobach |
| PPFIA3PPFI scaffold protein A3 | Często (30–79%) | W 1 chorobie |
| PPOXprotoporphyrinogen oxidase | Często (30–79%) | W 1 chorobie |
| PPP1CBprotein phosphatase 1 catalytic subunit beta | Często (30–79%) | W 1 chorobie |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Często (30–79%) | W 2 chorobach |
| PRKAR1Bprotein kinase cAMP-dependent type I regulatory subunit beta | Często (30–79%) | W 1 chorobie |
| PROK2prokineticin 2 | Często (30–79%) | W 1 chorobie |
| PROKR2prokineticin receptor 2 | Często (30–79%) | W 1 chorobie |
| PRPHperipherin | Często (30–79%) | W 1 chorobie |
| PRR12proline rich 12 | Często (30–79%) | W 1 chorobie |
| PSEN1presenilin 1 | Często (30–79%) | W 1 chorobie |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Często (30–79%) | W 1 chorobie |
| PTCH1patched 1 | Często (30–79%) | W 4 chorobach |
| PTRHD1peptidyl-tRNA hydrolase domain containing 1 | Często (30–79%) | W 1 chorobie |
| RAD21RAD21 cohesin complex component | Często (30–79%) | W 1 chorobie |
| RPS20ribosomal protein S20 | Często (30–79%) | W 1 chorobie |
| RREB1ras responsive element binding protein 1 | Często (30–79%) | W 1 chorobie |
| RRP12ribosomal RNA processing 12 homolog | Często (30–79%) | W 2 chorobach |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Często (30–79%) | W 2 chorobach |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Często (30–79%) | W 2 chorobach |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Często (30–79%) | W 2 chorobach |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Często (30–79%) | W 2 chorobach |
| SEC24CSEC24 homolog C, COPII component | Często (30–79%) | W 1 chorobie |
| SEMA4Asemaphorin 4A | Często (30–79%) | W 1 chorobie |
| SETD1BSET domain containing 1B, histone lysine methyltransferase | Często (30–79%) | W 1 chorobie |
| SGCEsarcoglycan epsilon | Często (30–79%) | W 2 chorobach |
| SHHsonic hedgehog signaling molecule | Często (30–79%) | W 4 chorobach |
| SIX3SIX homeobox 3 | Często (30–79%) | W 4 chorobach |
| SLC20A2solute carrier family 20 member 2 | Często (30–79%) | W 1 chorobie |
| SLC2A3solute carrier family 2 member 3 | Często (30–79%) | W 1 chorobie |
| SLC35C1solute carrier family 35 member C1 | Często (30–79%) | W 1 chorobie |
| SMC1Astructural maintenance of chromosomes 1A | Często (30–79%) | W 2 chorobach |
| SMC3structural maintenance of chromosomes 3 | Często (30–79%) | W 1 chorobie |
| SMC5structural maintenance of chromosomes 5 | Często (30–79%) | W 1 chorobie |
| SOD1superoxide dismutase 1 | Często (30–79%) | W 1 chorobie |
| SOX5SRY-box transcription factor 5 | Często (30–79%) | W 2 chorobach |
| SPECC1Lsperm antigen with calponin homology and coiled-coil domains 1 like | Często (30–79%) | W 1 chorobie |
| SPRY4sprouty RTK signaling antagonist 4 | Często (30–79%) | W 1 chorobie |
| SQSTM1sequestosome 1 | Często (30–79%) | W 1 chorobie |
| STAG2STAG2 cohesin complex component | Często (30–79%) | W 3 chorobach |
| STILSTIL centriolar assembly protein | Często (30–79%) | W 4 chorobach |
| STUB1STIP1 homology and U-box containing protein 1 | Często (30–79%) | W 1 chorobie |
| TAC3tachykinin precursor 3 | Często (30–79%) | W 1 chorobie |
| TACR3tachykinin receptor 3 | Często (30–79%) | W 1 chorobie |
| TAF1TATA-box binding protein associated factor 1 | Często (30–79%) | W 1 chorobie |
| TAF15TATA-box binding protein associated factor 15 | Często (30–79%) | W 1 chorobie |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Często (30–79%) | W 1 chorobie |
| TANC2tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 | Często (30–79%) | W 1 chorobie |
| TARDBPTAR DNA binding protein | Często (30–79%) | W 1 chorobie |
| TBCBtubulin folding cofactor B | Często (30–79%) | W 1 chorobie |
| TBK1TANK binding kinase 1 | Często (30–79%) | W 1 chorobie |
| TBX1T-box transcription factor 1 | Często (30–79%) | W 2 chorobach |
| TERTtelomerase reverse transcriptase | Często (30–79%) | W 1 chorobie |
| TET3tet methylcytosine dioxygenase 3 | Często (30–79%) | W 1 chorobie |
| TGFBR2transforming growth factor beta receptor 2 | Często (30–79%) | W 1 chorobie |
| TGIF1TGFB induced factor homeobox 1 | Często (30–79%) | W 4 chorobach |
| THRBthyroid hormone receptor beta | Często (30–79%) | W 1 chorobie |
| TLK2tousled like kinase 2 | Często (30–79%) | W 1 chorobie |
| TLR7toll like receptor 7 | Często (30–79%) | W 1 chorobie |
| TM2D3TM2 domain containing 3 | Często (30–79%) | W 1 chorobie |
| TMCO1transmembrane and coiled-coil domains 1 | Często (30–79%) | W 1 chorobie |
| TMEM106Btransmembrane protein 106B | Często (30–79%) | W 1 chorobie |
| TNFSF4TNF superfamily member 4 | Często (30–79%) | W 1 chorobie |
| TOR1Atorsin family 1 member A | Często (30–79%) | W 1 chorobie |
| TP53tumor protein p53 | Często (30–79%) | W 1 chorobie |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Często (30–79%) | W 1 chorobie |
| TREM2triggering receptor expressed on myeloid cells 2 | Często (30–79%) | W 2 chorobach |
| UBAP2Lubiquitin associated protein 2 like | Często (30–79%) | W 1 chorobie |
| UBQLN2ubiquilin 2 | Często (30–79%) | W 1 chorobie |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Często (30–79%) | W 1 chorobie |
| VAPBVAMP associated protein B and C | Często (30–79%) | W 1 chorobie |
| VCPvalosin containing protein | Często (30–79%) | W 3 chorobach |
| VPS13Avacuolar protein sorting 13 homolog A | Często (30–79%) | W 2 chorobach |
| WACWW domain containing adaptor with coiled-coil | Często (30–79%) | W 3 chorobach |
| WARS2tryptophanyl tRNA synthetase 2, mitochondrial | Często (30–79%) | W 1 chorobie |
| WDR11WD repeat domain 11 | Często (30–79%) | W 1 chorobie |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Często (30–79%) | W 1 chorobie |
| ZIC2Zic family zinc finger 2 | Często (30–79%) | W 4 chorobach |
| ZNF365zinc finger protein 365 | Często (30–79%) | W 1 chorobie |
| ZNRF3zinc and ring finger 3 | Często (30–79%) | W 1 chorobie |
| ACSL4acyl-CoA synthetase long chain family member 4 | Czasami (5–29%) | W 1 chorobie |
| ADGRV1adhesion G protein-coupled receptor V1 | Czasami (5–29%) | W 2 chorobach |
| ALADaminolevulinate dehydratase | Czasami (5–29%) | W 1 chorobie |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Czasami (5–29%) | W 1 chorobie |
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Czasami (5–29%) | W 1 chorobie |
| APC2APC regulator of Wnt signaling pathway 2 | Czasami (5–29%) | W 1 chorobie |
| ARID2AT-rich interaction domain 2 | Czasami (5–29%) | W 1 chorobie |
| ARL6ARF like GTPase 6 | Czasami (5–29%) | W 1 chorobie |
| ARSGarylsulfatase G | Czasami (5–29%) | W 1 chorobie |
| ASCC3activating signal cointegrator 1 complex subunit 3 | Czasami (5–29%) | W 1 chorobie |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Czasami (5–29%) | W 2 chorobach |
| ATP7BATPase copper transporting beta | Czasami (5–29%) | W 1 chorobie |
| BBIP1BBSome interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| BBS1Bardet-Biedl syndrome 1 | Czasami (5–29%) | W 1 chorobie |
| BBS10Bardet-Biedl syndrome 10 | Czasami (5–29%) | W 1 chorobie |
| BBS12Bardet-Biedl syndrome 12 | Czasami (5–29%) | W 1 chorobie |
| BBS2Bardet-Biedl syndrome 2 | Czasami (5–29%) | W 1 chorobie |
| BBS4Bardet-Biedl syndrome 4 | Czasami (5–29%) | W 1 chorobie |
| BBS5Bardet-Biedl syndrome 5 | Czasami (5–29%) | W 1 chorobie |
| BBS7Bardet-Biedl syndrome 7 | Czasami (5–29%) | W 1 chorobie |
| BBS9Bardet-Biedl syndrome 9 | Czasami (5–29%) | W 1 chorobie |
| BCL11BBCL11 transcription factor B | Czasami (5–29%) | W 1 chorobie |
| CABP4calcium binding protein 4 | Czasami (5–29%) | W 1 chorobie |
| CACNA1Hcalcium voltage-gated channel subunit alpha1 H | Czasami (5–29%) | W 1 chorobie |
| CAPRIN1cell cycle associated protein 1 | Czasami (5–29%) | W 1 chorobie |
| CBScystathionine beta-synthase | Czasami (5–29%) | W 1 chorobie |
| CCND1cyclin D1 | Czasami (5–29%) | W 1 chorobie |
| CDC42BPBCDC42 binding protein kinase beta | Czasami (5–29%) | W 1 chorobie |
| CDH2cadherin 2 | Czasami (5–29%) | W 1 chorobie |
| CDH23cadherin related 23 | Czasami (5–29%) | W 1 chorobie |
| CEACAM3CEA cell adhesion molecule 3 | Czasami (5–29%) | W 1 chorobie |
| CEACAM6CEA cell adhesion molecule 6 | Czasami (5–29%) | W 1 chorobie |
| CEP19centrosomal protein 19 | Czasami (5–29%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Czasami (5–29%) | W 1 chorobie |
| CEP78centrosomal protein 78 | Czasami (5–29%) | W 1 chorobie |
| CFAP418cilia and flagella associated protein 418 | Czasami (5–29%) | W 1 chorobie |
| CFTRCF transmembrane conductance regulator | Czasami (5–29%) | W 1 chorobie |
| CHRNA2cholinergic receptor nicotinic alpha 2 subunit | Czasami (5–29%) | W 1 chorobie |
| CHRNA4cholinergic receptor nicotinic alpha 4 subunit | Czasami (5–29%) | W 1 chorobie |
| CHRNB2cholinergic receptor nicotinic beta 2 subunit | Czasami (5–29%) | W 1 chorobie |
| CICcapicua transcriptional repressor | Czasami (5–29%) | W 1 chorobie |
| CLCA4chloride channel accessory 4 | Czasami (5–29%) | W 1 chorobie |
| CLCN4Cl-/H+ antiporter 4 | Czasami (5–29%) | W 2 chorobach |
| CLRN1clarin 1 | Czasami (5–29%) | W 1 chorobie |
| CRHcorticotropin releasing hormone | Czasami (5–29%) | W 1 chorobie |
| CTCFCCCTC-binding factor | Czasami (5–29%) | W 1 chorobie |
| DCTN4dynactin subunit 4 | Czasami (5–29%) | W 1 chorobie |
| DDB1damage specific DNA binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Czasami (5–29%) | W 1 chorobie |
| DLATdihydrolipoamide S-acetyltransferase | Czasami (5–29%) | W 1 chorobie |
| DNAJC6DnaJ heat shock protein family (Hsp40) member C6 | Czasami (5–29%) | W 1 chorobie |
| DNMT3ADNA methyltransferase 3 alpha | Czasami (5–29%) | W 1 chorobie |
| DPH1diphthamide biosynthesis 1 | Czasami (5–29%) | W 1 chorobie |
| DPH2diphthamide biosynthesis 2 | Czasami (5–29%) | W 1 chorobie |
| EDNRAendothelin receptor type A | Czasami (5–29%) | W 1 chorobie |
| EFHC1EF-hand domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| EHMT1euchromatic histone lysine methyltransferase 1 | Czasami (5–29%) | W 2 chorobach |
| ESPNespin | Czasami (5–29%) | W 1 chorobie |
| FMO3flavin containing dimethylaniline monoxygenase 3 | Czasami (5–29%) | W 1 chorobie |
| FRMD5FERM domain containing 5 | Czasami (5–29%) | W 1 chorobie |
| FTSJ1FtsJ RNA 2'-O-methyltransferase 1 | Czasami (5–29%) | W 1 chorobie |
| FXNfrataxin | Czasami (5–29%) | W 1 chorobie |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Czasami (5–29%) | W 1 chorobie |
| GALTgalactose-1-phosphate uridylyltransferase | Czasami (5–29%) | W 1 chorobie |
| GCLCglutamate-cysteine ligase catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| GLAgalactosidase alpha | Czasami (5–29%) | W 1 chorobie |
| GNASGNAS complex locus | Czasami (5–29%) | W 4 chorobach |
| GNB1G protein subunit beta 1 | Czasami (5–29%) | W 1 chorobie |
| GRIK2glutamate ionotropic receptor kainate type subunit 2 | Czasami (5–29%) | W 1 chorobie |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Czasami (5–29%) | W 2 chorobach |
| GSTM3glutathione S-transferase mu 3 | Czasami (5–29%) | W 1 chorobie |
| GUK1guanylate kinase 1 | Czasami (5–29%) | W 1 chorobie |
| H1-4H1.4 linker histone, cluster member | Czasami (5–29%) | W 1 chorobie |
| HARS1histidyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| HECTD4HECT domain E3 ubiquitin protein ligase 4 | Czasami (5–29%) | W 1 chorobie |
| HEXBhexosaminidase subunit beta | Czasami (5–29%) | W 1 chorobie |
| HFEhomeostatic iron regulator | Czasami (5–29%) | W 1 chorobie |
| HIVEP2HIVEP zinc finger 2 | Czasami (5–29%) | W 1 chorobie |
| HMBShydroxymethylbilane synthase | Czasami (5–29%) | W 2 chorobach |
| HMOX1heme oxygenase 1 | Czasami (5–29%) | W 1 chorobie |
| HSPG2heparan sulfate proteoglycan 2 | Czasami (5–29%) | W 1 chorobie |
| HTRA2HtrA serine peptidase 2 | Czasami (5–29%) | W 1 chorobie |
| IFNGinterferon gamma | Czasami (5–29%) | W 1 chorobie |
| IFT172intraflagellar transport 172 | Czasami (5–29%) | W 1 chorobie |
| IFT27intraflagellar transport 27 | Czasami (5–29%) | W 1 chorobie |
| IFT74intraflagellar transport 74 | Czasami (5–29%) | W 1 chorobie |
| IGF1Rinsulin like growth factor 1 receptor | Czasami (5–29%) | W 1 chorobie |
| JRKJrk helix-turn-helix protein | Czasami (5–29%) | W 1 chorobie |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| KCNN4potassium calcium-activated channel subfamily N member 4 | Czasami (5–29%) | W 1 chorobie |
| KCNT1potassium sodium-activated channel subfamily T member 1 | Czasami (5–29%) | W 1 chorobie |
| KMT2Blysine methyltransferase 2B | Czasami (5–29%) | W 1 chorobie |
| LAMP2lysosome associated membrane protein 2 | Czasami (5–29%) | W 1 chorobie |
| LGI3leucine rich repeat LGI family member 3 | Czasami (5–29%) | W 1 chorobie |
| LRRK2leucine rich repeat kinase 2 | Czasami (5–29%) | W 1 chorobie |
| LZTFL1leucine zipper transcription factor like 1 | Czasami (5–29%) | W 1 chorobie |
| MAMLD1mastermind like domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| MAN2B1mannosidase alpha class 2B member 1 | Czasami (5–29%) | W 2 chorobach |
| MAPK1mitogen-activated protein kinase 1 | Czasami (5–29%) | W 1 chorobie |
| MED12Lmediator complex subunit 12L | Czasami (5–29%) | W 1 chorobie |
| MEFVMEFV innate immunity regulator, pyrin | Czasami (5–29%) | W 1 chorobie |
| MEN1menin 1 | Czasami (5–29%) | W 1 chorobie |
| MIFmacrophage migration inhibitory factor | Czasami (5–29%) | W 1 chorobie |
| MIR17HGmiR-17-92a-1 cluster host gene | Czasami (5–29%) | W 1 chorobie |
| MKKSMKKS centrosomal shuttling protein | Czasami (5–29%) | W 1 chorobie |
| MKS1MKS transition zone complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| MYO7Amyosin VIIA | Czasami (5–29%) | W 2 chorobach |
| MYT1Lmyelin transcription factor 1 like | Czasami (5–29%) | W 1 chorobie |
| NAGSN-acetylglutamate synthase | Czasami (5–29%) | W 1 chorobie |
| NAXENAD(P)HX epimerase | Czasami (5–29%) | W 1 chorobie |
| NEXMIFneurite extension and migration factor | Czasami (5–29%) | W 1 chorobie |
| NFIBnuclear factor I B | Czasami (5–29%) | W 1 chorobie |
| NOTCH3notch receptor 3 | Czasami (5–29%) | W 1 chorobie |
| NPHP1nephrocystin 1 | Czasami (5–29%) | W 1 chorobie |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Czasami (5–29%) | W 1 chorobie |
| NSD1nuclear receptor binding SET domain protein 1 | Czasami (5–29%) | W 1 chorobie |
| OTCornithine transcarbamylase | Czasami (5–29%) | W 1 chorobie |
| PAK3p21 (RAC1) activated kinase 3 | Czasami (5–29%) | W 1 chorobie |
| PCDH15protocadherin related 15 | Czasami (5–29%) | W 1 chorobie |
| PDE10Aphosphodiesterase 10A | Czasami (5–29%) | W 1 chorobie |
| PDZD7PDZ domain containing 7 | Czasami (5–29%) | W 1 chorobie |
| PINK1PTEN induced kinase 1 | Czasami (5–29%) | W 2 chorobach |
| PODXLpodocalyxin like | Czasami (5–29%) | W 1 chorobie |
| PPM1Dprotein phosphatase, Mg2+/Mn2+ dependent 1D | Czasami (5–29%) | W 1 chorobie |
| PRKNparkin RBR E3 ubiquitin protein ligase | Czasami (5–29%) | W 1 chorobie |
| PTBP1polypyrimidine tract binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| PTPAprotein phosphatase 2 phosphatase activator | Czasami (5–29%) | W 1 chorobie |
| PURApurine rich element binding protein A | Czasami (5–29%) | W 1 chorobie |
| RFX7regulatory factor X7 | Czasami (5–29%) | W 1 chorobie |
| RIMS2regulating synaptic membrane exocytosis 2 | Czasami (5–29%) | W 1 chorobie |
| RNF125ring finger protein 125 | Czasami (5–29%) | W 1 chorobie |
| RPS6KC1ribosomal protein S6 kinase C1 | Czasami (5–29%) | W 1 chorobie |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Czasami (5–29%) | W 2 chorobach |
| SATB2SATB homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| SCAPERS-phase cyclin A associated protein in the ER | Czasami (5–29%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Czasami (5–29%) | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Czasami (5–29%) | W 1 chorobie |
| SERPINA1serpin family A member 1 | Czasami (5–29%) | W 1 chorobie |
| SETBP1SET binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| SETD1ASET domain containing 1A, histone lysine methyltransferase | Czasami (5–29%) | W 1 chorobie |
| SGSM3small G protein signaling modulator 3 | Czasami (5–29%) | W 1 chorobie |
| SIN3ASIN3 transcription regulator family member A | Czasami (5–29%) | W 1 chorobie |
| SLC11A1solute carrier family 11 member 1 | Czasami (5–29%) | W 1 chorobie |
| SLC25A4solute carrier family 25 member 4 | Czasami (5–29%) | W 1 chorobie |
| SLC26A9solute carrier family 26 member 9 | Czasami (5–29%) | W 1 chorobie |
| SLC4A10solute carrier family 4 member 10 | Czasami (5–29%) | W 1 chorobie |
| SLC6A14solute carrier family 6 member 14 | Czasami (5–29%) | W 1 chorobie |
| SLC7A6OSsolute carrier family 7 member 6 opposite strand | Czasami (5–29%) | W 1 chorobie |
| SLC9A3solute carrier family 9 member A3 | Czasami (5–29%) | W 1 chorobie |
| SNCAsynuclein alpha | Czasami (5–29%) | W 1 chorobie |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Czasami (5–29%) | W 1 chorobie |
| SPARTspartin | Czasami (5–29%) | W 1 chorobie |
| SPTBN1spectrin beta, non-erythrocytic 1 | Czasami (5–29%) | W 1 chorobie |
| SRCAPSnf2 related CREBBP activator protein | Czasami (5–29%) | W 1 chorobie |
| SRPX2sushi repeat containing protein X-linked 2 | Czasami (5–29%) | W 1 chorobie |
| SRRM2serine/arginine repetitive matrix 2 | Czasami (5–29%) | W 1 chorobie |
| STEEP1STING1 ER exit protein 1 | Czasami (5–29%) | W 1 chorobie |
| STX16syntaxin 16 | Czasami (5–29%) | W 1 chorobie |
| SYNJ1synaptojanin 1 | Czasami (5–29%) | W 1 chorobie |
| SYT1synaptotagmin 1 | Czasami (5–29%) | W 1 chorobie |
| TCF12transcription factor 12 | Czasami (5–29%) | W 1 chorobie |
| TGFB1transforming growth factor beta 1 | Czasami (5–29%) | W 1 chorobie |
| THOC2THO complex subunit 2 | Czasami (5–29%) | W 2 chorobach |
| TMEM147transmembrane protein 147 | Czasami (5–29%) | W 1 chorobie |
| TREX1three prime repair exonuclease 1 | Czasami (5–29%) | W 1 chorobie |
| TRIM32tripartite motif containing 32 | Czasami (5–29%) | W 1 chorobie |
| TRIP12thyroid hormone receptor interactor 12 | Czasami (5–29%) | W 1 chorobie |
| TSC1TSC complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| TSC2TSC complex subunit 2 | Czasami (5–29%) | W 1 chorobie |
| TTC8tetratricopeptide repeat domain 8 | Czasami (5–29%) | W 1 chorobie |
| TTRtransthyretin | Czasami (5–29%) | W 1 chorobie |
| TWNKtwinkle mtDNA helicase | Czasami (5–29%) | W 1 chorobie |
| UCHL1ubiquitin C-terminal hydrolase L1 | Czasami (5–29%) | W 1 chorobie |
| USH1CUSH1 protein network component harmonin | Czasami (5–29%) | W 1 chorobie |
| USH1GUSH1 protein network component sans | Czasami (5–29%) | W 1 chorobie |
| USH2Ausherin | Czasami (5–29%) | W 1 chorobie |
| VHLvon Hippel-Lindau tumor suppressor | Czasami (5–29%) | W 1 chorobie |
| VPS13Cvacuolar protein sorting 13 homolog C | Czasami (5–29%) | W 1 chorobie |
| WDPCPWD repeat containing planar cell polarity effector | Czasami (5–29%) | W 1 chorobie |
| WDR45WD repeat domain 45 | Czasami (5–29%) | W 1 chorobie |
| WHRNwhirlin | Czasami (5–29%) | W 1 chorobie |
| YY1YY1 transcription factor | Czasami (5–29%) | W 3 chorobach |
| ZBTB20zinc finger and BTB domain containing 20 | Czasami (5–29%) | W 1 chorobie |
| ZFXzinc finger protein X-linked | Czasami (5–29%) | W 1 chorobie |
| ZRSR2zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | Czasami (5–29%) | W 1 chorobie |
| CPA6carboxypeptidase A6 | Rzadko (1–4%) | W 1 chorobie |
| EBF3EBF transcription factor 3 | Rzadko (1–4%) | W 1 chorobie |
| FA2Hfatty acid 2-hydroxylase | Rzadko (1–4%) | W 1 chorobie |
| FGF13fibroblast growth factor 13 | Rzadko (1–4%) | W 1 chorobie |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Rzadko (1–4%) | W 1 chorobie |
| HCN1hyperpolarization activated cyclic nucleotide gated potassium channel 1 | Rzadko (1–4%) | W 1 chorobie |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Rzadko (1–4%) | W 1 chorobie |
| PRRT2proline rich transmembrane protein 2 | Rzadko (1–4%) | W 1 chorobie |
| SLC32A1solute carrier family 32 member 1 | Rzadko (1–4%) | W 1 chorobie |
| STX1Bsyntaxin 1B | Rzadko (1–4%) | W 1 chorobie |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Nie odnotowano | W 1 chorobie |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Nie odnotowano | W 1 chorobie |
| CLN3CLN3 lysosomal/endosomal transmembrane protein, battenin | Nie odnotowano | W 1 chorobie |
| CPOXcoproporphyrinogen oxidase | Nie odnotowano | W 1 chorobie |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Nie odnotowano | W 1 chorobie |
| HTR2A5-hydroxytryptamine receptor 2A | Nie odnotowano | W 1 chorobie |
| JPH3junctophilin 3 | Nie odnotowano | W 1 chorobie |
| KMT2Elysine methyltransferase 2E (inactive) | Nie odnotowano | W 1 chorobie |
| NFASCneurofascin | Nie odnotowano | W 1 chorobie |
| NKX2-1NK2 homeobox 1 | Nie odnotowano | W 1 chorobie |
| PAHphenylalanine hydroxylase | Nie odnotowano | W 1 chorobie |
| PDE11Aphosphodiesterase 11A | Nie odnotowano | W 1 chorobie |
| PPP2R2Bprotein phosphatase 2 regulatory subunit Bbeta | Nie odnotowano | W 1 chorobie |
| PQBP1polyglutamine binding protein 1 | Nie odnotowano | W 1 chorobie |
| RLIMring finger protein, LIM domain interacting | Nie odnotowano | W 1 chorobie |
| SETD2SET domain containing 2, histone lysine methyltransferase | Nie odnotowano | W 1 chorobie |
| SLC45A1solute carrier family 45 member 1 | Nie odnotowano | W 1 chorobie |
| SLC6A4solute carrier family 6 member 4 | Nie odnotowano | W 1 chorobie |
| TCF20transcription factor 20 | Nie odnotowano | W 1 chorobie |
| TTC19tetratricopeptide repeat domain 19 | Nie odnotowano | W 1 chorobie |
| XKX-linked Kx blood group antigen, Kell and VPS13A binding protein | Nie odnotowano | W 1 chorobie |
| YWHAGtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni